Blackstone Group L.P. has agreed to buy a stake in China's Xinrong Best Medical Instrument Co, the U.S. private equity firm said in a statement on Tuesday.

Blackstone did not give the size of the stake or other financial details.

A person with direct knowledge of the matter said Blackstone is investing around $100 million in the company, which makes orthopaedic implants. The person declined to be identified as details of the transaction were private.

Boston Consulting Group projects the China orthopaedic implant market to grow to $4.1 billion in 2020 from $1.3 billion in 2013, driven by an ageing population and increasing affordability of treatment.

 

Related Articles

Other News

Reuters Exclusive: American Lawyer publisher up for sale - sources

by Reuters |

American Lawyer publisher ALM Media, which was once controlled by Wall Street dealmaker Bruce Wasserstein, is exploring a sale that could fetch more than $500 million, people familiar with the matter said.

Appointments

K&L Gates hires corporate partner in Beijing from A&O

by Liu Zhen |

K&L Gates has hired corporate partner Frank Voon in Beijing from Allen & Overy, marking the U.S. firm’s seventh partner recruitment in the Asia-Pacific region in the first three months of 2014.

Appointments

Fenwick & West hires M&A partner from Kaye Scholer in Shanghai

by Shangjing Li |

Fenwick & West has bolstered its M&A practice in China after hiring Niping Wu from Kaye Scholer as a corporate partner in the firm’s Shanghai office.